Terms: = Skin cancer AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4 AND Prognosis
2985 results:
1. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
[TBL] [Abstract] [Full Text] [Related]
2. Low-Level Expression of p-S6 Is Associated with Nodal Metastasis in Patients with Head and Neck Cutaneous Squamous Cell Carcinoma.
Gómez-de Castro C; Santos-Juanes R; Nuñez-Gómez B; Fernández-Vega I; Vivanco B; Fernández-Velasco A; Reyes-García S; Carrero-Martín J; García-Pedrero JM; Rodrigo JP; González-Vela MDC; Santos-Juanes J; Galache C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673889
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical Characteristics of CD4
He HS; Wei YF; Ji XY; Xu YH; Yang YQ; Jin XK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study.
Ertekin SS; Mangas C; Riquelme-Mc Loughlin C; Carrera C; Malvehy J; Puig S; Podlipnik S
Acta Derm Venereol; 2024 Apr; 104():adv27571. PubMed ID: 38655656
[TBL] [Abstract] [Full Text] [Related]
5. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.
Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J
BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216
[TBL] [Abstract] [Full Text] [Related]
6. Could the mitotic count improve personalized prognosis in melanoma patients?
Buja A; Rugge M; Cozzolino C; Dossi F; Zorzi M; Vecchiato A; de Luca G; Del Fiore P; Tropea S; dall'Olmo L; Rossi CR; Boccuzzo G; Mocellin S
PLoS One; 2024; 19(4):e0302309. PubMed ID: 38626072
[TBL] [Abstract] [Full Text] [Related]
7. Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon: a retrospective study.
Py C; De Vito C; Tsantoulis P; Kaya G; Labidi-Galy SI; Dietrich PY
Swiss Med Wkly; 2023 Dec; 153():3504. PubMed ID: 38579317
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy of Cemiplimab as Adjuvant or Neoadjuvant Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma.
Hiller A; Oxford M; Kulkarni P; Fornadley J; Lo A; Sivik J; Drabick J; Vakharia K
Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S129-S131. PubMed ID: 38556660
[TBL] [Abstract] [Full Text] [Related]
9. 5-Methylcytosine immunohistochemistry for predicting cutaneous melanoma prognosis.
Meevassana J; Varophas S; Prabsattru P; Kamolratanakul S; Ruangritchankul K; Kitkumthorn N
Sci Rep; 2024 Mar; 14(1):7554. PubMed ID: 38555324
[TBL] [Abstract] [Full Text] [Related]
10. CD146 as a prognostic marker in breast cancer: A meta-analysis.
Sharma A; Somasundaram I; Chabaud MB
J Cancer Res Ther; 2024 Jan; 20(1):193-198. PubMed ID: 38554320
[TBL] [Abstract] [Full Text] [Related]
11. Efficiency and tolerance of second-line triple BRAF inhibitor/MEK inhibitor/anti-PD1 combined therapy in BRAF mutated melanoma patients with central nervous system metastases occurring during first-line combined targeted therapy: a real-life survey.
Fabre M; Lamoureux A; Meunier L; Samaran Q; Lesage C; Girard C; Du Thanh A; Moulis L; Dereure O
Melanoma Res; 2024 Jun; 34(3):241-247. PubMed ID: 38546723
[TBL] [Abstract] [Full Text] [Related]
12. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
[TBL] [Abstract] [Full Text] [Related]
13. Investigational Approaches for Treatment of Melanoma Patients Progressing After Standard of Care.
Fletcher KA; Johnson DB
Cancer J; 2024 Mar-Apr 01; 30(2):126-131. PubMed ID: 38527267
[TBL] [Abstract] [Full Text] [Related]
14. Malignancy After Living Donor Liver Transplantation.
Kobayashi T; Miura K; Ishikawa H; Sakata J; Takizawa K; Hirose Y; Toge K; Saito S; Abe S; Kawachi Y; Ichikawa H; Shimada Y; Takahashi Y; Wakai T; Kinoshita Y
Transplant Proc; 2024 Apr; 56(3):660-666. PubMed ID: 38519268
[TBL] [Abstract] [Full Text] [Related]
15. Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma.
Su DG; Schoenfeld DA; Ibrahim W; Cabrejo R; Djureinovic D; Baumann R; Rimm DL; Khan SA; Halaban R; Kluger HM; Olino K; Galan A; Clune J
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519058
[TBL] [Abstract] [Full Text] [Related]
16. Cutaneous Metastases: Clinicopathologic Study of 30 Patients.
Zaouak A; Ebdelli W; Slimène MB; Smida W; Debbiche A; Jannet SB; Hammami H; Fenniche S
Skinmed; 2024; 22(1):30-34. PubMed ID: 38494612
[TBL] [Abstract] [Full Text] [Related]
17. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
18. Tumor-infiltrating macrophage associated lncRNA signature in cutaneous melanoma: implications for diagnosis, prognosis, and immunotherapy.
Wan Q; Deng Y; Wei R; Ma K; Tang J; Deng YP
Aging (Albany NY); 2024 Mar; 16(5):4518-4540. PubMed ID: 38475660
[TBL] [Abstract] [Full Text] [Related]
19. Vacuum bell therapy for pectus excavatum: a retrospective study.
Lei W; Shao M; Hu Y; Cao J; Han W; Wang R; Fei Q; Zou J; Yi J; Cheng Z; Liu W
BMC Pediatr; 2024 Mar; 24(1):173. PubMed ID: 38461230
[TBL] [Abstract] [Full Text] [Related]
20. Right Thigh Mass Metastasis from Lung cancer Mimicking Primary Soft Tissue Sarcoma: A Case Report.
Putro YAP; Prasetyo TE; Magetsari R; Pribadi AW; Dwianingsih EK; Huwaidi AF
Am J Case Rep; 2024 Mar; 25():e942416. PubMed ID: 38429923
[TBL] [Abstract] [Full Text] [Related]
[Next]
